JPH0987268A - Purification of zopfielin - Google Patents

Purification of zopfielin

Info

Publication number
JPH0987268A
JPH0987268A JP24296795A JP24296795A JPH0987268A JP H0987268 A JPH0987268 A JP H0987268A JP 24296795 A JP24296795 A JP 24296795A JP 24296795 A JP24296795 A JP 24296795A JP H0987268 A JPH0987268 A JP H0987268A
Authority
JP
Japan
Prior art keywords
zofierin
component
ring
solution
solution containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP24296795A
Other languages
Japanese (ja)
Inventor
Akihito Nagamura
聡仁 長村
Hidenori Aoki
秀憲 青木
Tetsuo Nishimura
哲夫 西村
Itaru Kinoshita
格 木下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd, Nissan Chemical Corp filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP24296795A priority Critical patent/JPH0987268A/en
Publication of JPH0987268A publication Critical patent/JPH0987268A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To purify zopfielin useful as a germicide or an antithrombotic agent, etc., by making the compound basic and absorbing it into an anion exchange resin. SOLUTION: A solution containing (A) a compound represented by the formula or (B) a compound having a structure of a dicarboxylic acid or tetracarboxylic acid obtained by opening one or two rings of diketone furan structure which the component A has is made basic and absorbed into an anionic exchange resin and the component A or the component B is eluted with a solution containing an acid or inorganic salt from the resin and the component A is deposited by making the eluate acidic and purified. Furthermore, a culture medium, etc., obtained by culturing a microorganism belonging to the genus zophielin, e.g. Zopfiella curvata (FERM P-13067) is preferably used as the solution containing the component A or the component B.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は殺菌剤または抗血栓
剤などに有用なゾフィエリンの精製法に関する。
TECHNICAL FIELD The present invention relates to a method for purifying zofierin useful as a bactericidal agent or an antithrombotic agent.

【0002】[0002]

【従来の技術】式(I):2. Description of the Related Art Formula (I):

【化2】 で表される化合物(ゾフィエリン)は、ゾフィエラ(Zo
pfiella )属に属する微生物が生産する物質であり、抗
菌活性および抗血栓剤としての活性を有することが知ら
れている(特開平6−184157号公報)。
Embedded image Compound represented by (Zofierin) is Zofiera (Zo
It is a substance produced by a microorganism belonging to the genus pfiella ) and is known to have antibacterial activity and activity as an antithrombotic agent (JP-A-6-184157).

【0003】ゾフィエリンを単離する方法として、ゾフ
ィエラ属に属する微生物を培養して得られる培養液を濾
過し、得られた培養濾液を酸性とした後に酢酸エチルで
抽出し、抽出液をシリカゲルクロマトグラフィーおよび
ゲル濾過クロマトグラフィーを用いて精製し、さらに高
速液体クロマトグラフィーを用いて分取精製する方法が
知られている。
As a method for isolating zofierin, a culture solution obtained by culturing a microorganism belonging to the genus Zophieella is filtered, the obtained culture filtrate is acidified and then extracted with ethyl acetate, and the extract is subjected to silica gel chromatography. And a method of purifying using gel filtration chromatography and further preparative purification using high performance liquid chromatography is known.

【0004】しかし、該方法は、シリカゲルクロマトグ
ラフィーを含む多段階のクロマトグラフィーを使用する
こと、酢酸エチル、ベンゼン等の有機溶剤を多量に使用
することなどから工業的には不利な方法である。また、
ゾフィエリンは該方法により白色粉末として得られてい
るに過ぎず、これまで充分な純度が確保されていない。
However, this method is industrially disadvantageous because it uses multi-step chromatography including silica gel chromatography and uses a large amount of organic solvents such as ethyl acetate and benzene. Also,
Zophieline was only obtained as a white powder by this method, and a sufficient purity has not been secured so far.

【0005】一方、ゾフィエリンは、抽出条件等によ
り、ゾフィエリンがもつジケトフラン構造の1または2
個が開環したジカルボン酸またはテトラカルボン酸の構
造を有する化合物となり得ることが知られている(特開
平6−184157号公報)。
On the other hand, zofierin has a diketofuran structure of 1 or 2 depending on the extraction conditions.
It is known that a compound having a ring-opened dicarboxylic acid or tetracarboxylic acid structure can be obtained (JP-A-6-184157).

【0006】しかし、開環体が、いかなる条件下でゾフ
ィエリンとなり得るかについては知られていない。
However, it is not known under what conditions the ring-opened product can become zofierin.

【0007】[0007]

【発明が解決しようとする課題】殺菌剤または抗血栓剤
などに有用なゾフィエリンを工業的規模で効率的に精製
する方法を提供することを目的とする。
An object of the present invention is to provide a method for efficiently purifying zofierin, which is useful as a bactericide or antithrombotic agent, on an industrial scale.

【0008】[0008]

【課題を解決するための手段】本発明によれば、ゾフィ
エリンが塩基性条件下で開環体に、開環体が酸性条件下
でゾフィエリンに、それぞれ容易に変換することを利用
することにより、ゾフィエリンを陰イオン交換樹脂を用
いて精製する方法が提供される。
According to the present invention, by utilizing the fact that zofierin is easily converted into a ring-opened product under basic conditions and the ring-opened product is converted to zofierin under acidic conditions, respectively, A method for purifying zofierin using an anion exchange resin is provided.

【0009】すなわち、本発明はゾフィエリンまたは開
環体を含有する溶液を塩基性として陰イオン交換樹脂に
吸着させ、該樹脂から酸または無機塩を含む水溶液でゾ
フィエリンまたは開環体を溶出させ、溶出液を酸性とし
てゾフィエリンを析出させることよりなるゾフィエリン
の精製法を提供する。
That is, according to the present invention, a solution containing zofierin or a ring-opened product is made basic and adsorbed on an anion exchange resin, and the zofierin or ring-opened product is eluted from the resin with an aqueous solution containing an acid or an inorganic salt and eluted. Provided is a method for purifying zofierin, which comprises precipitating zofierin by acidifying a liquid.

【0010】[0010]

【発明の実施の形態】本発明に用いるゾフィエリンまた
は開環体を含有する溶液としては、ゾフィエラ属に属す
る微生物、例えばゾフィエラ・カルバータ(Zopfiella
curvata )No.37-3株(FERM P−13067)
を培養して得られる培養液(特開平6−184157号
公報)等が挙げられる。
BEST MODE FOR CARRYING OUT THE INVENTION As a solution containing zofierin or a ring-opened product used in the present invention, a microorganism belonging to the genus Zophieella, for example, Zopfiella carba
curvata ) No.37-3 strain (FERM P-13067)
A culture solution (Japanese Patent Laid-Open No. 184157/1994) obtained by cultivating the above is mentioned.

【0011】本発明に用いる溶液がゾフィエラ属に属す
る微生物を培養して得られる培養液である場合は、その
まま用いてもよいが、該培養液を遠心分離または濾過を
行うことにより菌体と培養濾液とに分離して、それぞれ
を用いてもよい。菌体を用いる場合、菌体をそのまま、
または菌体を超音波、ボールミル、ホモゲナイザー等で
破砕して用いてもよいし、さらにメタノール、エタノー
ル、プロパノール、ブタノール、アセトン、酢酸エチ
ル、アセトニトリル、クロロホルム等の有機溶媒(以
下、単に有機溶媒ともいう)により抽出して得られる溶
媒抽出物として用いてもよい。培養濾液を用いる場合、
培養濾液をそのまま、または濃縮して用いてもよい。
When the solution used in the present invention is a culture solution obtained by culturing a microorganism belonging to the genus Zophieella, it may be used as it is, but the culture solution is subjected to centrifugation or filtration to cultivate the bacterial cells. You may separate it into a filtrate and use each. When using bacterial cells,
Alternatively, the cells may be crushed with an ultrasonic wave, a ball mill, a homogenizer or the like, and further, an organic solvent such as methanol, ethanol, propanol, butanol, acetone, ethyl acetate, acetonitrile, chloroform (hereinafter, also simply referred to as an organic solvent. ), And may be used as a solvent extract obtained by extraction. When using the culture filtrate,
The culture filtrate may be used as it is or after being concentrated.

【0012】本発明に用いる溶液は、水酸化ナトリウ
ム、水酸化カリウム、アンモニア水等で塩基性、好まし
くはpH8〜14に調整した後、陰イオン交換樹脂、好
ましくは強塩基性陰イオン交換樹脂に吸着させる。な
お、ゾフィエリンから開環体への変換反応は、pH8の
水溶液中で反応温度30℃の場合、通常4時間で終了す
る。
The solution used in the present invention is adjusted to be basic, preferably at a pH of 8 to 14 with sodium hydroxide, potassium hydroxide, aqueous ammonia, etc., and then converted to an anion exchange resin, preferably a strongly basic anion exchange resin. Adsorb. The conversion reaction from zofierin to a ring-opened product is usually completed in 4 hours in an aqueous solution of pH 8 at a reaction temperature of 30 ° C.

【0013】陰イオン交換樹脂としては、市販のものと
して、例えばDIAION PA304、PA308、
PA412、(以上、三菱化学社製)、AMBERLI
TEIRA−400、IRA−904、A−27(以
上、ローム・アンド・ハース社製)、DOWEX 1、
2、11(以上、ダウケミカル社製)、DUOLITE
ES−109、A−101D(以上、デュオライト社
製)等が用いられる。
As the anion exchange resin, commercially available products such as DIAION PA304, PA308,
PA412, (Made by Mitsubishi Chemical Corporation), AMBERLI
TEIRA-400, IRA-904, A-27 (above, manufactured by Rohm and Haas), DOWEX 1,
2, 11 (above, Dow Chemical Co.), DUOLITE
ES-109, A-101D (above, manufactured by Duolite) and the like are used.

【0014】塩基性に調整した溶液に含まれる開環体を
陰イオン交換樹脂に吸着させるためには、該溶液と陰イ
オン交換樹脂とを単に混合するだけでもよいし、陰イオ
ン交換樹脂を充填したカラムに該溶液をSV0.1 〜3
の流速で通液してもよい。
In order to adsorb the ring-opened compound contained in the solution adjusted to be basic to the anion exchange resin, the solution may be simply mixed with the anion exchange resin, or the anion exchange resin may be filled. SV0.1 ~ 3
The liquid may be passed at a flow rate of.

【0015】開環体を吸着させた陰イオン交換樹脂を洗
浄せずに、または水もしくは水を含む有機溶媒(以下、
含水有機溶媒という)を通液して洗浄後、該陰イオン交
換樹脂に酸もしくは無機塩を含む水または酸もしくは無
機塩を含む含水有機溶媒(以下、溶出液という)をSV
0.1〜3の流速で通液してゾフィエリンまたは開環体
を溶出する。
Without washing the anion exchange resin adsorbing the ring-opened product, or water or an organic solvent containing water (hereinafter,
After washing with water containing organic solvent), water containing an acid or an inorganic salt in the anion exchange resin or a water containing organic solvent containing an acid or an inorganic salt (hereinafter referred to as an eluate) is SV.
The solution is passed through at a flow rate of 0.1 to 3 to elute zofierin or the ring-opened product.

【0016】酸としては、塩酸、硫酸、硝酸等が用いら
れ、酸性、好ましくはpH1〜4となるように溶出液に
添加される。
As the acid, hydrochloric acid, sulfuric acid, nitric acid or the like is used, and it is added to the eluate so as to be acidic, preferably pH 1-4.

【0017】無機塩としては、ナトリウム、カリウム、
カルシウム、アンモニウムからなる塩酸塩、硫酸塩、硝
酸塩、炭酸塩、重炭酸塩等が用いられ、塩濃度が1〜5
mol/Lとなるように溶出液に添加される。
As the inorganic salt, sodium, potassium,
Hydrochlorides, sulfates, nitrates, carbonates, bicarbonates and the like composed of calcium and ammonium are used, and the salt concentration is 1 to 5
It is added to the eluate so that it becomes mol / L.

【0018】ゾフィエリンまたは開環体を含む溶出液を
そのまま、または該溶出液に含まれる有機溶媒を留去
後、酸性、好ましくはpH1〜4に調整することによ
り、ゾフィエリンが結晶または沈殿物として析出してく
る。なお、開環体からゾフィエリンへの変換反応は、p
H2の水溶液中で反応温度30℃の場合、通常2時間で
終了する。
The eluate containing zofierin or the ring-opened product is used as it is, or after the organic solvent contained in the eluate is distilled off, the pH is adjusted to acidic, preferably pH 1 to 4, so that zofierin is precipitated as crystals or precipitates. Come on. In addition, the conversion reaction from the ring-opened form to zofierin is
When the reaction temperature is 30 ° C in an aqueous solution of H2, the reaction is usually completed in 2 hours.

【0019】析出したゾフィエリンは、遠心分離、濾
過、洗浄、乾燥等の通常の操作により、結晶または粉末
として得ることができる。
The precipitated zofierin can be obtained as crystals or powder by usual operations such as centrifugation, filtration, washing and drying.

【0020】[0020]

【実施例】【Example】

実施例1 ゾフィエラ・カルバータ No.37-3株をポテトデキストロ
ース培地(ディフコ社製)を含有する液体培地(pH
7.0)に植菌し、25℃で5日間培養した。得られた
培養液をポテトデキストロース培地にポリペプトン0.
1%、酵母エキス0.1%、トマトジュース(食塩添
加、カゴメ社製)10%(W/W)を添加してなる培地
(pH7.0)に接種し、140rpm、25℃で12
日間振盪培養を行った。
Example 1 A liquid medium (pH) containing Zofierella carbata No. 37-3 strain containing a potato dextrose medium (manufactured by Difco)
7.0), and cultured at 25 ° C. for 5 days. The obtained culture broth was added to potato dextrose medium to obtain polypeptone (0.1%).
1%, yeast extract 0.1%, tomato juice (added salt, manufactured by Kagome Co., Ltd.) 10% (W / W) was added to the medium (pH 7.0) and inoculated to the medium (140 rpm, 25 ° C, 12).
Shaking culture was performed for one day.

【0021】培養終了後、培養液14Lに同量のアセト
ンを添加して1時間攪拌後、濾過して濾液を得た。濾液
を吸着レジンSP−207(三菱化学社製)350ml
に吸着させ、60%アセトン1050mlで洗浄した
後、70%アセトンで溶出した。溶出液を蒸発乾固させ
た後、メタノール100mlを添加して溶解させた。溶
解液に水40mlを添加し、室温にて4時間攪拌した
後、分離機にて回収して乾燥させることにより高速液体
クロマトグラフィー(以下、HPLCという)純度90
%のゾフィエリンの粉末が5.7g得られた。
After the completion of the culture, the same amount of acetone was added to 14 L of the culture solution, and the mixture was stirred for 1 hour and filtered to obtain a filtrate. The filtrate is 350 ml of adsorption resin SP-207 (manufactured by Mitsubishi Chemical Corporation).
It was adsorbed on and washed with 1050 ml of 60% acetone, and then eluted with 70% acetone. After the eluate was evaporated to dryness, 100 ml of methanol was added and dissolved. 40 ml of water was added to the solution, and the solution was stirred at room temperature for 4 hours, collected by a separator and dried to obtain high performance liquid chromatography (hereinafter, referred to as HPLC) purity 90.
5.7 g of% zofierin powder was obtained.

【0022】得られたゾフィエリン5gを水500ml
に懸濁後、水酸化ナトリウムによりpH10に調整し、
4時間攪拌した。なお、得られた溶液についてHPLC
および薄層クロマトグラフィー(以下、TLCという)
を用いて以下の条件で分析したところ、該溶液中には開
環体のみが検出された。 HPLC カラム:GL-pack nucleosil 5C18 I.D.4.6mm×150mm
(GLサイエンス社製) 移動層:0.05Mリン酸緩衝液(pH6)/アセトニ
トリル=4/6 カラム温度:35℃ 流量:1.0ml/L 検出:UV254nm 保持時間:ゾフィエリン;9分、開環体;1.7分 TLC プレート:Merck HPTLC F254 展開相:トルエン:アセトン:酢酸=36:1:1 Rf値:ゾフィエリン;0.5、開環体;0.1 次に、該溶液をDIAION PA412を充填したカ
ラム(φ3cm×18cm)に流速125ml/hで通
液して吸着させ、水250mlを通液して未吸着物を除
去した後、1M硫酸ナトリウムを通液して溶出を行い、
溶出液625mlを開環体画分として取得した。この画
分を12N塩酸にてpH2に調整し、生じた結晶をバス
ケット分離機にて回収後、乾燥させることにより、HP
LC純度95%の結晶が4.5g得られた。得られた結
晶について、 1H−NMRおよび13C−NMRによる分
析を行った。
5 g of the obtained zofierin was added to 500 ml of water.
After suspension in, adjust to pH 10 with sodium hydroxide,
Stir for 4 hours. The obtained solution was analyzed by HPLC
And thin layer chromatography (hereinafter referred to as TLC)
When analyzed with the following conditions, only the ring-opened product was detected in the solution. HPLC column: GL-pack nucleosil 5C18 ID 4.6mm × 150mm
(GL Science) Mobile phase: 0.05 M phosphate buffer (pH 6) / acetonitrile = 4/6 Column temperature: 35 ° C. Flow rate: 1.0 ml / L Detection: UV254 nm Retention time: Zophieline; 9 minutes, ring opening Body; 1.7 minutes TLC plate: Merck HPTLC F 254 developing phase: toluene: acetone: acetic acid = 36: 1: 1 Rf value: Zophieline; 0.5, ring-opened body; 0.1 Next, the solution was treated with DIAION. A column (φ3 cm × 18 cm) packed with PA412 was passed at a flow rate of 125 ml / h for adsorption, 250 ml of water was passed therethrough to remove unadsorbed substances, and then 1M sodium sulfate was passed for elution.
625 ml of the eluate was obtained as a ring-opened body fraction. This fraction was adjusted to pH 2 with 12N hydrochloric acid, and the resulting crystals were collected with a basket separator and dried to give HP.
4.5 g of crystals having an LC purity of 95% were obtained. The obtained crystals were analyzed by 1 H-NMR and 13 C-NMR.

【0023】1H−NMR(400MHz,CDCl3)δ; 0.93(3H,
t,J=7.1Hz), 0.96(3H,t,J=7.1Hz), 1.36-1.44(8H,m),
1.65-1.70(3H,m), 1.74(1H,d,J=4.1Hz), 1.83(1H,m),
2.88-3.10(4H,m), 3.13(1H,dd,J=15.4,14.9Hz), 3.29(1
H,t,J=13.0Hz), 3.99(1H,m)13 C−NMR(100MHz,CDCl3)σ;13.8, 14.0, 18.5, 22.
4, 22.5, 25.0, 28.2, 28.5, 34.2, 34.9, 36.6, 41.7,
71.7, 141.0, 143.4, 145.1, 147.3, 165.0, 165.1, 1
65.4, 165.5 以上の結果より、得られた結晶がゾフィエリンであるこ
とを確認した。
1 H-NMR (400 MHz, CDCl 3 ) δ; 0.93 (3 H,
t, J = 7.1Hz), 0.96 (3H, t, J = 7.1Hz), 1.36-1.44 (8H, m),
1.65-1.70 (3H, m), 1.74 (1H, d, J = 4.1Hz), 1.83 (1H, m),
2.88-3.10 (4H, m), 3.13 (1H, dd, J = 15.4,14.9Hz), 3.29 (1
H, t, J = 13.0Hz), 3.99 (1H, m) 13 C-NMR (100MHz, CDCl 3 ) σ; 13.8, 14.0, 18.5, 22.
4, 22.5, 25.0, 28.2, 28.5, 34.2, 34.9, 36.6, 41.7,
71.7, 141.0, 143.4, 145.1, 147.3, 165.0, 165.1, 1
65.4, 165.5 From the above results, it was confirmed that the obtained crystal was zofierin.

【0024】実施例2 実施例1と同様な方法で得られた培養液10Lを、水酸
化ナトリウムによりpH8に調製し、4時間攪拌した。
この培養液にDIAION PA412を250ml添
加して5時間攪拌後、DIAION PA412のみを
回収率95%で捕集し、カラム(φ3.9cm×20c
m)に充填した。カラムに水500mlを通液して未吸
着物を除去した後、1N塩酸−メタノールを通液して溶
出を行った。溶出液1.5Lをゾフィエリン画分として
取得し、この画分に等量の水を添加した。生じた結晶を
バスケット分離機にて回収後、乾燥させることにより、
HPLC純度95%のゾフィエリンの結晶が4.5g得
られた。回収率は81%であった。
Example 2 10 L of the culture broth obtained in the same manner as in Example 1 was adjusted to pH 8 with sodium hydroxide and stirred for 4 hours.
To this culture solution, 250 ml of DIAION PA412 was added, and after stirring for 5 hours, only DIAION PA412 was collected at a recovery rate of 95%, and the column (φ3.9 cm × 20 c
m). 500 ml of water was passed through the column to remove unadsorbed substances, and then 1N hydrochloric acid-methanol was passed for elution. Eluate (1.5 L) was obtained as a zofierin fraction, and an equal amount of water was added to this fraction. After collecting the generated crystals with a basket separator, by drying,
4.5 g of zofierin crystals with an HPLC purity of 95% were obtained. The recovery rate was 81%.

【0025】実施例3 実施例1と同様な方法で得られた培養液10Lを菌体分
離を行い、その菌体を乾燥した。この乾燥菌体160g
を水に懸濁させ、懸濁液を水酸化ナトリウムによりpH
10に調整した。得られた溶液を濾過して得られた溶液
をDIAIONPA412を充填したカラム(φ3cm
×18cm)に流速125ml/hで通液し、開環体を
吸着させた。カラムに水250mlを通液して未吸着物
を除去した後、1M塩化ナトリウムを通液して溶出を行
い、開環体画分を875ml取得した。この画分を12
N塩酸によりpH2に調整して、生じた結晶をバスケッ
ト分離機にて回収後、乾燥させることにより、HPLC
純度95%のゾフィエリンの結晶が5g得られた。回収
率は88%であった。
Example 3 10 L of the culture solution obtained by the same method as in Example 1 was used to separate the cells, and the cells were dried. 160g of this dry cell
Is suspended in water and the suspension is adjusted to pH with sodium hydroxide.
Adjusted to 10. The solution obtained by filtering the obtained solution was used as a column packed with DIAIONPA412 (φ3 cm
(* 18 cm) at a flow rate of 125 ml / h to adsorb the ring-opened product. After 250 ml of water was passed through the column to remove unadsorbed substances, 1 M sodium chloride was passed for elution to obtain 875 ml of a ring-opened body fraction. This fraction 12
After adjusting the pH to 2 with N hydrochloric acid and collecting the resulting crystals with a basket separator, drying the crystals
5 g of crystals of zofierin with a purity of 95% were obtained. The recovery rate was 88%.

【0026】実施例4 実施例1と同様な方法で得られた培養液1000Lを硫
酸によりpH2に調整し、70℃で1時間攪拌後、濾過
により集菌した。集菌した菌体を水300Lに懸濁さ
せ、懸濁液を水酸化ナトリウムによりpH8に調整し、
4時間攪拌した。この懸濁液を濾過し、開環体を含む濾
液500Lを取得した。得られた濾液をDIAION
PA412を充填したカラム(φ22cm×53cm)
に流速20L/hで通液して開環体を吸着させた。カラ
ムに水140Lを通液して未吸着物を除去した後、1M
塩化アンモニウムを通液して溶出を行い、開環体画分を
140L取得した。この画分を12N塩酸によりpH2
に調整して、生じた結晶をバスケット分離機にて回収
後、乾燥させることにより、HPLC純度95%のゾフ
ィエリンの結晶が489g得られた。回収率は78%で
あった。
Example 4 1000 L of the culture solution obtained in the same manner as in Example 1 was adjusted to pH 2 with sulfuric acid, stirred at 70 ° C. for 1 hour, and then collected by filtration. Suspend the collected cells in 300 L of water, adjust the suspension to pH 8 with sodium hydroxide,
Stir for 4 hours. This suspension was filtered to obtain 500 L of the filtrate containing the ring-opened product. The obtained filtrate is treated with DIAION.
Column packed with PA412 (φ22cm × 53cm)
The ring-opened product was adsorbed by passing the solution at a flow rate of 20 L / h. After passing 140 L of water through the column to remove unadsorbed substances, 1 M
Elution was carried out by passing ammonium chloride, and 140 L of a ring-opened product fraction was obtained. This fraction was adjusted to pH 2 with 12N hydrochloric acid.
The resulting crystals were collected by a basket separator and dried to obtain 489 g of crystals of zofierin having an HPLC purity of 95%. The recovery rate was 78%.

【0027】[0027]

【発明の効果】本発明により、ゾフィエリンの工業的規
模での効率的な精製法が提供される。
Industrial Applicability According to the present invention, an efficient purification method of zofierin on an industrial scale is provided.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/34 ADZ A61K 31/34 ADZ C12P 17/18 C12P 17/18 D (C12P 17/18 C12R 1:645) (72)発明者 木下 格 山口県防府市協和町2−2−306─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location A61K 31/34 ADZ A61K 31/34 ADZ C12P 17/18 C12P 17/18 D (C12P 17/18 C12R 1: 645) (72) Inventor Satoshi Kinoshita 2-2-306 Kyowa Town, Hofu City, Yamaguchi Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 式(I): 【化1】 で表される化合物(以下、ゾフィエリンという)または
ゾフィエリンがもつジケトフラン構造の1または2個が
開環したジカルボン酸またはテトラカルボン酸の構造を
有する化合物(以下、開環体という)を含有する溶液を
塩基性として陰イオン交換樹脂に吸着させ、該樹脂から
酸または無機塩を含む水溶液でゾフィエリンまたは開環
体を溶出させ、溶出液を酸性としてゾフィエリンを析出
させることを特徴とするゾフィエリンの精製法。
1. Formula (I): A solution containing a compound represented by (hereinafter, referred to as zofierin) or a compound having a dicarboxylic acid or tetracarboxylic acid structure in which one or two diketofuran structures of zofierin are ring-opened (hereinafter, referred to as ring-opened body) A method for purifying zofierin, which comprises adsorbing a basic substance on an anion exchange resin, eluting zofierin or a ring-opened product from the resin with an aqueous solution containing an acid or an inorganic salt, and acidifying the eluate to precipitate zofierin.
JP24296795A 1995-09-21 1995-09-21 Purification of zopfielin Withdrawn JPH0987268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24296795A JPH0987268A (en) 1995-09-21 1995-09-21 Purification of zopfielin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24296795A JPH0987268A (en) 1995-09-21 1995-09-21 Purification of zopfielin

Publications (1)

Publication Number Publication Date
JPH0987268A true JPH0987268A (en) 1997-03-31

Family

ID=17096901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24296795A Withdrawn JPH0987268A (en) 1995-09-21 1995-09-21 Purification of zopfielin

Country Status (1)

Country Link
JP (1) JPH0987268A (en)

Similar Documents

Publication Publication Date Title
US7018814B2 (en) Process of purifying vancomycin hydrochloride
KR102015100B1 (en) Method for recovering or purifying gentamicin B from fermented culture medium of microorganism
JPH0987268A (en) Purification of zopfielin
JPS6133194A (en) Novel anthracycline antibiotic substance
US5519123A (en) Chelating agents, their preparation from the antibiotics salmycin A,B,C, or D, and their use
JP3883525B2 (en) Method for purifying pravastatin sodium
JPH036139B2 (en)
JP3030896B2 (en) WB968 substance group and production method thereof
JP2000125896A (en) Production of antitumor antibiotic dx-52-1
JPH05399B2 (en)
JP2690779B2 (en) L-ascorbic acid derivative and method for producing the same
JP2971128B2 (en) Purification method of mitomycin C
JP2000236894A (en) Production of radicicol
JP2873341B2 (en) Antibiotic TAN-950, its production and use
SU1547711A3 (en) Method of dawnorubicin-hydrochloride
JP2883708B2 (en) Dexirosylbenanomycin A, a new antifungal antibiotic and its production
JPH0123473B2 (en)
JPS60214890A (en) Production of l-carnitine and gamma-butyrobetaine
JPH06253869A (en) Purification of natural type abisic acid
JPS5927898A (en) Novel antibiotic and its preparation
JP2005295897A (en) Method for producing antibiotic yl-02729s substance
JPH04202176A (en) Purification of abscisic acid
JPH02291289A (en) Production of 1-deoxymannojirimycin
JPH0139436B2 (en)
JPH08245626A (en) New mitomycin

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20021203